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Highlights 
 Autism traits appear elevated in individuals experiencing a first episode of psychosis 
 Traits are likely to have a significant impact on symptoms of psychosis 
 Social and role functioning, and quality of life may also be affected 
 Autism traits are important even when they do not reach diagnostic levels for autism 
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Abstract    
Autism traits are found at elevated rates in individuals with schizophrenia spectrum disorders, 
however, there is a lack of evidence regarding potential clinical impact. The current research 
aimed to examine potential associations between autism traits and symptoms of psychosis, social 
and role functioning, and quality of life. 99 individuals experiencing a first episode of psychosis 
took part in a cross-sectional interview and self-report questionnaire which assessed current 
symptoms of psychosis, autism traits, functioning, and quality of life. Participants were found to 
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have a high level of autism traits. Higher autism traits were associated with poorer quality of life, 
functioning, and current psychotic symptoms. Receiver operating characteristic curve (ROC) 
analyses indicated that optimal AQ cut-off scores to predict severity of psychosis symptoms, 
functioning, and quality of life were lower than those used to suggest likely autism-spectrum 
diagnosis. Results suggest that autism traits are associated with poorer clinical presentation in 
first-episode psychosis populations, even in those whose traits fall below potentially diagnostic 
thresholds for autism. Psychosis services should be prepared to adequately address the needs of 
individuals with higher autism traits.  
Keywords: 
Autism traits; Functioning; Quality of life; Schizophrenia spectrum disorders  
 
1. Introduction  
Autism spectrum conditions (ASC) and schizophrenia spectrum disorders (SSD) are reported to 
co-occur at elevated rates (Davidson et al., 2014; Hofvander et al., 2009), and have been found to 
share many phenotypic and neurological similarities, and multiple risk factors (Carroll & Owen, 
2009; Cheung et al., 2010; Chisholm et al, 2015). As well as potentially shedding light on the 
fundamental aetiology of the conditions, understanding the similarities and differences between 
the conditions and the extent of the overlap may also aid with the development of specialised 
care models and service delivery.  
Much existing research has concentrated on diagnostic co-morbidity of ASC and SSD; however, 
more recently research has found the conditions co-occur at the trait level (Kincaidet al., 2017). 
This is important given that ASC and SSD are both hypothesised to exist on an extended 
continuum, with traits and symptoms varying from low, to mid, to potentially diagnostic levels 
(Constantino & Todd, 2003; Johns & van Os, 2001). This means that autism traits which do not 
reach diagnostic levels may still be clinically important in individuals with SSD, and it is therefore 
important that the potential impact of traits along the full range of this scale are understood. 
Autism traits have been found to be stable in SSD, and remain at the same levels regardless of 
remission of psychotic symptoms (in comparison to depression, for example, where remission 
from depression also leads to remission from the autism-like traits; Matsuo et al., 2015). This is 
important as it implies that the high levels of autism traits found in SSD populations are not 
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merely the result of current symptoms of psychosis. There is currently a lack of evidence 
regarding the clinical impact of autism traits in individuals with SSD. Current treatments for SSD 
are relatively effective with regards to positive symptoms, however longstanding challenges 
remain; in particular, patients with SSD often have enduring difficulties with functional recovery 
and quality of life. It is important that any role that autism traits may play in functioning and 
quality of life is examined. This knowledge will inform clinical practice decisions regarding the 
treatment and management of SSD.  
The Autism-Spectrum Quotient (AQ) is a questionnaire which was designed specifically to assess 
autism traits (as opposed to diagnosis). The AQ also provides general population cut offs for 
high and very high autism traits, which the authors of the AQ suggest are indicative that an ASC 
diagnosis may be appropriate (Baron-Cohen et al., 2001; Woodbury-Smith et al., 2005).  The AQ 
has been used previously with SSD populations to assess autism traits, finding high levels of 
autism traits compared to healthy controls (Koelkebeck et al., 2010; Lugnegård et al., 2015; 
Wouters & Spek, 2011) and that these traits are associated with regional neurological alterations 
(Sasamoto et al., 2011).  
The primary objective of this study was to examine the hypothesis that autism traits in 
individuals with psychosis will be significantly associated with clinically relevant variables, 
including symptoms of psychosis, functioning, and quality of life. Exploratory analyses 
additionally examined which AQ subscales may contribute to this association.  Secondary 
objectives of the study were to determine optimal cut-offs of the AQ with respect to these 
clinically relevant variables. The measurement of traits of autism in SSD populations is complex 
and validated instruments for autism assessment in this population do not currently exist. If 
measures of autism traits (such as the AQ) are measuring genuine traits then these should 
correlate with premorbid adjustment. A final objective of our research was therefore to examine 
the relationship between the AQ and premorbid adjustment. 
 
2. Methods 
2.1 Design:  
A cross-sectional design was used, consisting of a single assessment of interviewer and self-
reported measures conducted and scored by trained raters who were blind to participants AQ 
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scores. Consent was obtained from all participants. Ethical approval was granted by the UK 
Health Research Authority‘s National Research Ethics Service, reference number 13/WM/0213. 
2.2 Sampling:  
Outpatients presenting to Birmingham and Solihull Mental Health Foundation Trust Early 
Intervention Services (EIS) were invited to take part in the research. EIS provides clinical 
services for young people presenting in the early stages of psychotic illness. Inclusion criteria 
were individuals aged 16 years or above, diagnosed by EIS consultant psychiatrists in keeping 
with ICD-10 F20-23, F25-29. Consultant psychiatrists are trained in ICD-10 diagnosis, however 
no specific structured interview was used. Diagnoses were discussed during clinical team 
meetings to ensure diagnostic consensus. First episode of psychosis was established via 
discussion with EIS clinical teams to determine that participants had not had any previous 
episodes of psychosis. Exclusion criteria included a lack of capacity to consent and insufficient 
English language proficiency. With the exception of past psychotic illness (which would deem a 
person to not be experiencing a first episode of psychosis), past mental illness was not an 
exclusion criterion. EIS psychiatrists and care-coordinators were asked to systematically identify 
any individuals on their caseload who met the inclusion and exclusion criteria. Any individuals 
who met inclusion and exclusion criteria were then approached and asked if they would like to 
participate in the study. With the participant‘s consent their medical records were searched for 
primary diagnosis, diagnosis of autism, and medication. Participants were not antipsychotic-
naïve.  
2.3 Measures:  
Demographic information collected included age, gender, ethnicity, living situation, previous 
cannabis use, educational attainment, work/education status, parental age at birth, and family 
history of mental illness or autism. 
Psychotic symptoms: The Positive and Negative Syndrome Scale (PANSS; Kay et al., 1987) is a 
30-item, well-validated, interviewer-rated measure of Positive, Negative, and General psychotic 
symptoms occurring over the past week. Higher scores on the PANSS indicate greater symptom 
severity. 
Autism Traits: The Autism-Spectrum Quotient (AQ; Baron-Cohen et al., 2001) is a well-
validated 50-item self-report questionnaire. The AQ was designed as a measure of autism traits 
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along the wider autism-spectrum and is commonly employed as a screening instrument prior to 
ASC diagnosis (Woodbury-Smith et al., 2005). Higher scores on the AQ indicate a higher level of 
autism traits. Baron-Cohen et al. (2001) suggest that AQ scores of ≥32 indicate that an ASC 
diagnosis may be appropriate, and Woodbury-Smith et al. (2005) argue that individuals with ASC 
are unlikely to score below 26. These cut-offs were not used in the present study as a diagnostic 
tool, but were instead used to define high autism traits (≥26) and very high autism traits (≥32). 
The AQ assesses five domains: a preference for non-social situations or difficulty making friends 
increase participants‘ scores on the Social Skill subscale; inflexible or fixed attention, commonly 
reported in ASC, are assessed on the Attention Switching subscale; a focus on details to the 
exclusion of the bigger picture, and interest in patterns or numbers increase scores on the 
Attention to Detail subscale; difficulties or a lack of enjoyment in communicating with others is 
assessed on the Communication subscale; and difficulties in activities which involve an 
imagination component are assessed on the Imagination subscale. The AQ has previously been 
used as a measure of autism traits within SSD populations (Koelkebeck et al., 2010; Lugnegård et 
al., 2015; Wouters & Spek, 2011). 
Functioning and Quality of Life: Current functioning (defined as the past month) was assessed 
using the interviewer-rated Social and Occupational Functioning Assessment (SOFAS; Goldman 
et al., 1992) and Personal and Social Performance Scales (PSP; Morosini et al., 2000). Higher 
scores on both of these scales indicate a better level of personal, social, and role functioning. 
Current quality of life was measured with the interviewer-rated 21 item Quality of Life Scale 
(QoL; Heinrichs et al., 1984), which can be broken down into subscales representing Social 
Functioning, Engagement in Life, and Vocational Functioning (Shtasel et al., 1992). Higher 
scores on the QoL indicate a better quality of life. 
Premorbid Adjustment: The Premorbid Assessment of Functioning Scale (PAS; Cannon-Spoor, 
Potkin, and Wyatt) was used to assess premorbid functioning from childhood through to illness 
onset, across five areas of development; sociability and withdrawal, peer relationships, scholastic 
performance, adaption to school, and social sexual aspects of life. Higher scores on this scale are 
associated with lower levels of premorbid functioning. 
2.4 Analysis: 
Statistical analyses were conducted using SPSS version 22.0. In order to examine the hypothesis 
that autism traits in individuals with psychosis will be associated with clinically relevant variables, 
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including symptoms of psychosis, functioning, and quality of life a series of main regression 
analyses were run. Further exploratory post-hoc analyses then examined the relationship between 
which AQ subscales may contribute to this association.  
First, Mann-Whitney U (for scale variables) and Fishers exact tests (for categorical variables) 
were used to investigate any potential differences in demographics characteristics between high 
(≥32) and lower (<32) scorers on the AQ. To calculate whether potential confounders should be 
controlled for, correlations between continuous total AQ score and confounders were examined. 
Correlations between premorbid adjustment and autism were investigated using bivariate 
correlations. 
Second, where p<0.05 the confounder was included in the model. Qualification status (no 
qualification or basic qualification only vs higher level of qualification) was included as a 
potential confounder for the PANSS models. Qualification status and affective vs non-affective 
diagnosis were included as potential confounders in the QoL and Functioning (SOFAS and PSP) 
models.  
Type of regression used varied depending on whether assumptions were met or not. Multiple 
linear regression analyses were used where assumptions were met (Total QoL, Engagement QoL, 
PANSS General). If assumptions of normality were not met (based on a visual inspection of 
frequency distributions of outcomes, the Kolmogorov-Smirnov test, and normality of residuals), 
data were transformed using log transformations (PSP and PANSS Total) and multiple linear 
regression analyses were used. If transformation was not possible (Social QoL, Vocational QoL, 
SOFAS, PANSS Negative, and PANSS Positive) the variable was categorised into quartiles and 
multinomial logistic regression analyses were used with the 1st quartile (Q1) used as the reference 
category. Variance inflation factors showed acceptably low levels of multicollinearity between 
AQ subscales. In total, 10 main regressions were run (one for each outcome). A Bonferroni 
corrected alpha cut-off of 0.005 (0.05/10) was used to correct for inflation of the false positive 
rate due to multiple comparisons. Further exploratory post-hoc analyses were run without this 
conservative correction (alpha = 0.05). 
Third, to investigate the predictive value of AQ scores for the severity of psychotic symptoms, 
psychosocial functioning and quality of life, without a priori cut-offs, ROC-curves were calculated 
to evaluate the prognostic ability of AQ at different cut-offs. This allowed for quantification of 
the association between the AQ and the outcome across different AQ levels, giving insight into 
the level at which the predictor becomes indicative of a clinical problem (i.e. is this only at levels 
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of very high autism traits of ≥32?). Optimal prediction of the outcome was used as a criterion to 
select the most relevant AQ cut-off. This approach was chosen because it allowed for the 
identification of an optimal AQ score i.e. the AQ with optimal true positive rate, or sensitivity 
(SENS), and false positive rate, or specificity (SPEC) for insight into the general prognostic value 
of AQ score for poor outcome.   
In order to to identify the factors associated with the poorest functioning and most severe 
symptoms using ROC analyses, the outcomes were coded accordingly. The highest 25% (1) of 
PANSS scores (positive, negative, general and total) were compared to the remaining 75% (0) of 
PANSS scores. The lowest 25% (1) of SOFAS scores, QLS scores (total, social and engagement) 
and PSP scores were compared to the remaining 75% (0) of SOFAS, QLS and PSP scores. QLS 
vocational was not included because of a lack of variation in the scores in this sample. After 
calculation of the ROC-curves, the non-parametric area under the curve (AUC) was investigated. 
If the AUC was significantly different from 0.5 (=chance level prediction), the curve‘s SENS and 
SPEC coordinates were inspected to find the AQ score with the most optimal SENS/SPEC 
balance, which was selected based on the highest J-statistic (SENS+SPEC-1; Youden, 1950). 
Finally, SENS and SPEC were investigated for the AQ cut-offs of ≥32 (defined as very high 
autism traits in the present study and suggested by Baron-Cohen et al., 2001, as indicative that an 
autism spectrum diagnosis may be appropriate), and <26 (suggested by Woodbury-Smith et al., 
2005, as indicative that an autism spectrum diagnosis is highly unlikely).  
 
3. Results  
3.1 Demographic Information and premorbid adjustment 
Ninety nine individuals took part in the study, of whom 87 gave complete AQ data. Of these, 59 
(67.8%) participants were male (as is typical in psychosis populations; Aleman et al., 2003). The 
mean age of the sample was 25.5 years (SD=5.0). Just over half the sample (47 participants) 
identified as White British, with other common ethnicities including Asian Pakistani (7 
participants), Black Caribbean (5 participants), Mixed White and Black Caribbean (4 
participants), Asian Bangladeshi (4 participants), and White Other (4 participants). All other 
ethnicities were represented by less than 4% of participants. 41.4% of the sample had a 1st degree 
relative with a psychiatric condition including; a schizophrenia spectrum diagnosis (12.1%), a 
mood disorder (23.2%), an autism spectrum disorder (8%), and substance abuse (1%). The 
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majority (93.9%) of participants were currently being prescribed antipsychotic medication. 
Demographics of participants are reported in Table 1. No significant differences in demographic 
characteristics were found between those who reported very high levels of autism traits 
compared to participants with lower scores. As the main regression analyses use continuous AQ 
scores as the predictor variable, correlations between potential confounders and AQ score was 
also examined using a point-biserial correlation. This found significant correlations between the 
AQ and diagnosis (r=-0.3, p=0.01), and educational attainment (r=-0.2, p=0.04). These were 
therefore included as co-variates in all regression analyses. Autism and AQ data can be seen in 
Table 2. Four participants had a pre-existing diagnosis of autism. Due to the research aim of 
investigating autism traits across the entire continuum, these participants were included in all 
analyses.  
Premorbid adjustment, as measured by the PAS, was found to be significantly positively 
correlated with AQ Total (r=0.52, p<0.0001). Significant positive correlations were also found 
between the PAS and AQ Social (r=0.35, p=0.001), Attention Switching (r=0.44, p<0.0001), 
Communication (r=0.50, p<0.0001), and Imagination (r=0.34, p=0.001) subscales, but not with 
the Attention to Detail subscale. 
 
*Table 1 about here* 
 
*Table 2 about here* 
 
3.2 The relationship between AQ subscales and symptoms of psychosis, functioning, and quality of life 
Separate multiple linear regression main analyses (Table 3) showed that higher levels of autism 
traits were significantly associated with lower Total QoL. Exploratory post hoc analyses found 
that the specific autism traits which showed significant associations were Attention Switching 
and Imagination. Functioning, as measured by the PSP, was also associated with autism traits, 
with higher AQ scores predicting lower functioning. Post hoc analyses found the AQ subscale of 
Imagination showed significant effects. Autism traits were significantly associated with PANSS 
Total and General subscales in the main regression. Post hoc analyses found that this was driven 
by the AQ Communication subscale for both PANSS Total and General. The model for 
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Engagement QoL was significant, however this relationship was predominantly driven by 
Qualification attainment rather than autism traits. 
 
*Table 3 about here* 
Five separate multinomial logistic regression main analyses (Table 4) were conducted to 
investigate associations of AQ subscales with Social and Vocational QoL, the SOFAS, and 
PANSS Positive and Negative. For these the outcome variable was categorised into quartiles, and 
the multinomial logistic regression compared the 1st quartile (Q1) to each other quartile, in order 
to assess how the AQ was associated with the outcome variable. Odds ratios from the main 
analyses indicated that when the contributing AQ subscales were raised Social QoL and SOFAS 
scores decreased significantly, and PANSS negative scores increased. The multinomial logistic 
regression analyses for Vocational QoL and PANSS positive were not found to be significant at 
the corrected p-value of 0.005. 
Exploratory post hoc analyses indicated that on the Social QoL outcome, higher scores on AQ 
Imagination were associated with lower odds of being in the 2nd and 3rd quartiles compared to 
Q1, higher scores on AQ Attention to Detail with lower odds of being in the 3rd quartile, higher 
scores on the AQ Social subscale with lower odds of being in the 4th quartile, and higher scores 
on the AQ Attention switching subscale with lower odds of being in the 4th quartile. This 
indicates that higher scores on the AQ subscales of Social, Attention Switching, Attention to 
Detail, and Imagination may be associated with a reduction in Social QoL. For the SOFAS, 
higher scores on AQ Attention Switching were associated with lower odds of being in the 3rd and 
4th quartile compared to Q1, and higher scores on AQ Imagination were associated with lower 
odds of being in the 3rd quartile compared to Q1. This indicates that higher scores on the AQ 
subscales of Attention Switching and Imagination are associated with a reduction in functioning. 
For the PANSS negative, higher scores on AQ communication were associated with higher odds 
of being in the 3rd quartile compared to Q1, and higher scores on AQ Imagination were 
associated with higher odds of being in the 4th quartile compared to Q1. This indicates that 
higher scores on the AQ subscales of Communication and Imagination may be associated with 
an increase in negative symptoms. 
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*Table 4 about here* 
 
3.3 Optimal cut offs of AQ scores for the severity of psychotic symptoms, functioning and quality of life 
ROC-curves were calculated using AQ (range=5-42; M=20.76; SD=7.96) as a predictor variable. 
First, the AUCs for the ROCs with different outcomes were investigated to gain an overall 
insight of the association of AQ scores with poor outcome. For each ROC analysis conducted, 
the AUC differed significantly from 0.5, suggesting that total AQ was predictive of all the 
outcomes examined. AUC values ranged from 0.72 to 0.85. 
Next, we examined the optimal SENS/SPEC for each outcome. AQ scores between 19.5 and 
25.5 were the cut-offs for optimal SENS/SPEC, depending on the outcome of interest. The 
optimal AQ cut-off for each outcome is shown in Table 5. These observed optimal AQ cut-offs 
are lower than the published cut-offs of 26 and 32. These cut-offs had better SENS, but SPEC 
was compromised compared to the cut offs of 26 and 32. The J-statistic was lower for the cut-
offs of 26 and 32.  
 
*Table 5 about here* 
 
4. Discussion  
 
This is the first study to examine the association between traits of autism with current 
functioning, quality of life, and psychotic symptoms in a psychosis population. Higher levels of 
autism traits were found to be associated with lower quality of life, lower functioning, and higher 
levels of current psychotic symptoms. Exploratory post hoc analyses found that this association 
was particularly strong for the AQ Attention Switching and Imagination subscales for quality of 
life and functioning, and for the AQ Communication subscale for current total and negative 
psychotic symptoms. A ROC analysis indicated that autism traits which fall below potentially 
diagnostic levels may still be clinically important in relation to their impact on symptoms of 
psychosis, functioning, and quality of life. It is also of note that 8.1% participants had scores of 
≥32 (indicative of very high autism traits; Baron-Cohen et al., 2001) with just over a quarter of 
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participants scoring ≥26 (indicative of high autism traits; Woodbury-Smith et al., 2005). This 
compares to scores of ≥32 in just 2% of the general population (Baron-Cohen et al., 2001).  
Previously ASC have been shown to be related to increased risk factors for psychopathology 
(including psychosis), including increased exposure to negative life events (e.g. Maïano et al., 
2015), poorer coping styles (Mazefsky et al., 2014), reduced executive functioning (Merchán-
Naranjo et al., 2016), and reduced social support networks (Chamberlain et al., 2007). In non-
clinical populations, autism traits have been linked to lower quality of life, mediated by less 
successful coping styles (Pisula et al., 2015). Individuals with increased autism traits also report 
more loneliness (Jobe & White, 2007), and higher rates of adverse life events (Kunihira et al., 
2006). The AQ subscales of Attention Switching, Communication, and Imagination were found 
to drive many of the associations between the AQ and the clinically significant variables. 
Attention switching difficulties are part of the core diagnostic criteria for ASC, and are also 
common in SSD. In the general population, attention switching skills are hypothesised to 
underlie problem solving abilities (Byrne & Murray, 2005), suggesting that this may be a potential 
mediator between autism traits and psychosocial functioning in first-episode psychosis 
populations. Communication difficulties are also found in both ASC and SSD populations. 
Alexithymia describes a difficulty in identifying and communicating emotions, and is commonly 
found in ASC (Bird & Cook, 2013). In individuals with high autism traits, higher levels of 
alexithymia could potentially prevent early help-seeking, leading to under-reporting of 
psychopathology, increased duration of untreated illness, and more severe clinical outcomes.  
The ROC analyses showed that optimal AQ cut-offs for poor clinical outcome were lower than 
the cut-offs of 32 and 26 suggested as potentially indicative of ASC in the general population 
(Baron-Cohen et al., 2001; Woodbury-Smith et al., 2005). Optimal cut-offs varied from 19.5 to 
25.5. It is important that this finding is not taken to suggest that a lower AQ score may be 
indicative of autism in FEP populations. Rather, this is suggestive that in psychosis populations, 
levels of autism traits which fall below potentially diagnostic levels may still be highly clinically 
relevant in terms of their potential relationship with current symptoms of psychosis, quality of 
life, and functioning. This may be particularly the case for the variables where the lowest optimal 
cut offs were found (PANSS Negative, PANSS Total, and functional outcomes). It is important 
to note, however, that this is exploratory initial work and there is need for further confirmation 
and validation.  
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Premorbid adjustment was found to be significantly positively correlated with the AQ Total, 
meaning that higher autism traits were associated with lower premorbid adjustment. This is 
suggestive that the AQ was measuring genuine long term autism-like traits, as opposed to 
capturing a state-like refection of current psychotic illness.   
A number of models which may explain the co-occurrence of ASC and SSD have been proposed 
(Chisholm et al., 2015; Crespi & Badcock, 2008; Kraemer, 1995; Krueger & Markon, 2006). 
These include the diametric model, which hypothesises that ASC and SSD originate from 
opposing alterations to a common risk factor, and are therefore related in a reciprocal manner 
(Crespi & Badcock, 2008). The diametric model suggests that when individuals experience high 
levels of both psychotic-like and autism-like traits, behaviour, symptoms, and functioning will be 
modulated diametrically back towards normality. Whilst counterintuitive, there is emerging 
neurological (Abu-Akel et al., 2017; Ciaramidaro et al., 2014) and cognitive (Abu-Akel et al., 
2015) research which supports this theory, particularly within non-clinical populations. The 
current study found that in a population with psychosis (all of whom can therefore be 
considered to be ‗high psychosis‘), higher levels of autism traits were not associated with an 
ameliorating impact on symptoms and functioning, and were instead related to a lower quality of 
life, lower functioning, and higher levels of psychotic symptoms. This suggests that within 
clinical psychosis populations, the diametric model may be less applicable than in non-clinical 
populations. Much of the existing research into the diametric model has investigated the impact 
of autism and psychosis traits on theory of mind and mentalising ability (Abu-Akel et al., 2017; 
Abu-Akel et al., 2015; Ciaramidaro et al., 2014). It is possible that the diametric impact of autism 
and psychosis is restricted to these areas, although recent research suggests this is unlikely, 
finding that in neurotypical adults there may be a diametric effect of autism and psychosis traits 
on atypical responses to salient information (Abu-Akel et al., 2016). It is also possible that the 
diametric model may be more applicable to certain subgroups of diagnoses than others, and 
further research is needed to elucidate this. As the diametric model hypotheses an ameliorating 
effect of autism traits on psychosis and vice versa, it is possible that individuals with high levels 
of autism traits and psychosis traits would not be found in clinical samples, and would only be 
found in a general population sample. This is a potential explanation for the lack of supporting 
evidence for the diametric model in the current sample, however, some of the study participants 
did report relatively high levels of autism traits, and 4 individuals had a pre-existing diagnosis of 
autism. If the diametric model is correct, it seems likely that within the present sample, 
individuals reporting higher levels of autism traits should have shown some level of amelioration 
in their psychosis symptoms, functioning, or quality of life, even if this amelioration effect was 
         
14 
 
not strong. The observation that the opposite pattern occurred, with those with higher autism 
traits reporting higher psychosis symptoms, and lower functioning and quality of life, suggests 
that the diametric model does not apply to the current sample. 
The study has a number of limitations. The AQ was used rather than a diagnostic measure such 
as the Autism Diagnostic Interview-Revised (ADI-R) (Rutter et al, 2003) or the Autism 
Diagnostic Observation Schedule (ADOS) (Lord et al., 2000). This was due to the fact that 
whilst the ADI-R and ADOS are considered to be gold standard assessment tools for the 
diagnosis of autism, the focus of this study was on traits of autism rather than diagnosis. Neither 
the ADI-R nor the ADOS is specifically designed to measure traits of autism, whereas the AQ 
was designed with this in mind. The AQ has previously been used as a measure of autism traits 
within SSD populations (Koelkebeck et al., 2010; Lugnegård et al., 2015; Wouters & Spek, 2011), 
however, the measurement of traits of autism in SSD populations is complex and validated 
instruments for autism assessment in this population do not currently exist. Similarly, validated 
measures do not exist for the measurement of negative symptoms of psychosis in ASC 
populations. The relationship between autism traits and psychosis is not yet fully understood and 
various models which might explain this co-occurrence have been proposed (Chisholm et al., 
2015). Many symptoms or experiences which are found in one disorder are also found in the 
other (for example, the attention switching difficulties which are part of the core ASC criteria 
and are also found at high rates in SSD), meaning that instruments which assess autism traits in 
the general population may be less accurate in SSD populations. It is important that researchers 
take this into consideration. Matsuo et al.‘s (2015) finding that autism traits are stable in SSD 
populations, alongside our finding that the AQ correlated with premorbid adjustment, does 
however, suggest that autism traits found in SSD populations can be considered genuine traits 
rather than as merely reflective of current symptoms of psychosis (this can be contrasted with 
autism traits in depression, where remission from depression led to individuals no longer 
experiencing the autism-like traits; Matsuo et al., 2015). Until the association between ASC and 
SSD is better understood, researchers (particularly those conducting cross-sectional research) 
and clinicians must be careful not to allow negative symptoms of psychosis to mask potential 
autism traits, which may be less apparent than autism of a diagnosable level. It is possible that 
autism traits may be misdiagnosed or mislabelled as psychotic symptoms by clinicians on initial 
presentation to services. The best way to tease this apart would be to either to know about 
previous trait presentation or to assess the trajectory over the treatment period and see if AQ 
scores decline with psychosis symptom resolution (which they should not if they are traits). For 
the current research, it is important to note that the AQ assessment is a self-reported response to 
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clear ‗trait‘ questions, and is not externally assessed. In relation to this, we decided against 
controlling for PANSS symptoms in the current analysis (for the QoL and Functioning 
outcomes). This was due to the potential for interviewer ratings on the PANSS to be reflecting 
autism traits rather than genuine symptoms of psychosis, and therefore to mask the impact of 
any genuine autism traits.  
It is possible that the associations found in the present research between the AQ and the 
variables of interest may be mediated by other variables such as negative symptoms of psychosis, 
depression, lower IQ, education, or medication. The current sample is not large enough to 
investigate mediation via path analysis however this would be interesting to pursue in future 
studies. In addition, future studies should take into account duration of untreated psychosis, as 
this has been robustly associated with psychotic symptoms, functioning and quality of life 
(Marshall, Lewis, and Lockwood, 2005). The sampling method used in the study recruitment was 
not random, but relied on clinical care teams introducing the study to service users, which may 
have biased the sample of participants. The use of self-report instruments in psychosis 
populations is relatively common, however, ‗informant‘ information from family, friends, or 
clinical services on traits of autism in participants may aid the reliability of the assessment and 
should be considered for future research. Future research could also investigate the clinical 
impact of autism traits on particular subgroups of people with psychotic disorder, including 
schizophrenia or non-affective psychosis, childhood onset schizophrenia, and deficit 
schizophrenia, as some subgroups may have a stronger association with autism than others 
(Padgett et al, 2010; Sprong et al., 2008). Additionally, as a cross-sectional study, speculation on 
causality in the present study is limited, and further prospective research is needed.  
It is important that psychosis services have built in systems to adequately address the needs of 
individuals with higher autism traits. These could include the screening of all newly referred 
individuals for autism traits, and adapted interventions for high trait individuals. For example, 
simple structural elements such as planning, maintaining consistency and structure should be 
considered. In addition, communication (verbal and written) and checking of understanding may 
be of particular importance in individuals with high ASC traits. Clinicians may need to be aware 
of the need for ‗sameness‘, routine, and structure in interactions with individuals with high 
autism traits. It is important that clinical teams support individuals with their autism traits to full 
recovery from psychotic symptoms, but recognise autism traits rather than attributing all 
difficulties to psychosis. As risk factors for psychosis and other psychopathology is increased in 
those with high levels of autism traits (Jobe & White, 2007; Kunihira et al., 2006; Maïano et al., 
         
16 
 
2015), alongside reduced coping skills (Pisula et al., 2015), all clinical services should be aware 
and able to tailor their approach and treatment appropriately. An example of this can be seen in 
the autism clinic at Orygen Youth Health, Australia, which recognised the need to expand autism 
services within the public mental health sector during times of transition (such as adolescence 
and young adulthood) when the risk of a person with an ASC developing a comorbid mental 
health problem increases. The role of the autism clinic thus far has included providing 
comprehensive multidisciplinary diagnostic assessments for ASCs, and provision of both primary 
and secondary consultations relating to ASC within the other clinical programs of Orygen Youth 
Health. Another key component of the service has been capacity building and training of staff 
within Orygen Youth Health. Future research should also investigate whether recognised 
interventions, such as cognitive-behavioural therapy for psychosis, can be adapted for individuals 
with a high level of autism traits. Investigating autism diagnoses and traits in individuals who 
may be at risk for psychosis may also be beneficial for understanding how the disorders interact 
to exacerbate or ameliorate each other as psychosis develops.  
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Table 1: Demographic Characteristics of participants, and significance of difference between those who reported 
very high levels of traits on the AQ (defined by a score of 32 or over) compared to participants with lower scores   
 All Score of <32 on 
AQ (n=79) 
Score of ≥32 on 
AQ (n=8) 
Significance of 
difference, p value 
Age (Mean, SD) 25.5 (5.0) 25.5 (5.0) 25.9 (6.8) 0.9   
Gender (n, % male) 59 (67.7) 53 (67.1) 6 (75.0)  1 
Medication (n, % not drug 
naïve) 
83 (95.4) 76 (96.2) 7 (87.5)  0.3 
Mother‘s age when born 
(Mean, SD) 
25.8 (6.8) 25.8 (6.8) 26.3 (5.3) 0.7 
Father‘s age when born 
(Mean, SD) 
28.8 (7.6) 28.8 (7.6) 29.2 (4.1) 0.6 
Cannabis (n, % previously 
smoked) 
58 (66.7) 53 (67.1) 5 (62.5) 1 
Age at first smoking 
cannabis (Mean, SD) 
15.5 (2.7) 15.5 (2.7) 16.0 (2.2) 0.6 
Living situation (n, % 
Living independently) 
34 (39.1) 32 (40.5) 2 (25.0) 0.5 
Relationship status (n, % 
single/never married)  
70 (80.5) 63 (79.7) 7 (87.5) 1 
Educational attainment (n, 
% no qualifications) 
8 (9.3) 7 (9) 1 (12.5) 0.6 
Employment status (n, % 
not in education or 
employment) 
49 (57.6) 42 (54.5) 7 (87.5) 0.1 
History of family mental 
illness (n, % positive family 
history) 
36 (41.4) 31 (39.2) 5 (62.5) 0.3 
Diagnosis (n, % Affective 
diagnosis)  
17 (19.5) 17 (21.5) 0 (0) 0.3 
Mann-Whitney U used for scale variables and Fishers exact test for categorical variables   
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Table 2: Autism, AQ, and outcome data 
 ASC diagnosis in 
medical notes n (%) 
AQ score range 
(mean/SD) 
AQ score ≥26  
n (%) 
AQ score ≥32  
n (%) 
All participants 4 (5.0) 5-42 (20.8/7.96) 25 (28.7) 8 (9.2) 
Male 3 (3.4) 6-42 (21.5/8.17) 18 (30.5) 6 (10.2) 
Female 1 (1.1) 5-32 (19.2/7.39) 7 (25.0) 2 (7.1) 
 All participants 
mean (SD) 
AQ score <26 
mean (SD) 
AQ score ≥26  
mean (SD) 
AQ score ≥32  
mean (SD) 
Total QoL 76.42 (26.75) 82.37 (25.58) 62.35 (19.72) 56.88 (32.80) 
Engagement 
QoL 
34.18 (8.14) 35.71 (7.96) 31.76 (7.06) 27.75 (9.51) 
Vocational QoL 12.61 (11.40) 14.21 (11.46) 8.29 (9.22) 7.75 (11.02) 
Social QoL 29.62 (12.98) 32.45 (12.35) 22.29 (10.46) 21.38 (15.40) 
SOFAS 51.86 (19.37) 55.05 (20.00) 43.18 (12.26) 41.38 (13.96) 
PSP 50.72 (20.28) 54.55 (20.43) 41.59 (12.26) 38.38 (15.62) 
PANSS Total 51.08 (15.54) 46.62 (13.46) 62.25 (13.99) 64.00 (17.63) 
PANSS Positive 12.34 (5.65) 10.98 (4.76) 16.29 (6.32) 15.75 (6.80) 
PANSS 
Negative 
12.36 (5.29) 11.40 (4.76) 14.88 (6.17) 16.13 (4.85) 
PANSS General 26.42 (7.45) 24.33 (6.60) 31.18 (6.44) 32.13 (8.10) 
 
Table 3: Associations of autism traits with quality of life, current functioning, and current symptoms; multiple linear 
regression analyses. 
 R² F p-value 
for F 
Effect size 
(Cohen's f2) 
β 95% CI p-value 
for t    
Quality of life         
Total Score 0.45 9.30 <0.0001 0.82    
 AQ Social     -0.10 -3.31, 1.29 0.4 
 AQ Attention Switching     -0.35 -6.83, -1.56 0.002 
 AQ Attention to Detail     0.11 -0.39, 3.80 0.1 
 AQ Communication      0.04 -2.56, 3.36 0.8 
  AQ Imagination     -0.27 -5.89, -0.95 0.007 
 Qualification attainment     0.28 5.43, 25.95 0.003 
 Affective diagnosis     0.08 -6.69, 17.92 0.4 
Engagement 0.41 7.84 <0.0001 0.69    
 AQ Social     -0.08 -0.98, 0.49 0.5 
 AQ Attention Switching     -0.22 -1.65, 0.03 0.06 
 AQ Attention to Detail     0.13 -0.17, 1.17 0.1 
  AQ Communication     -0.05 -1.13, 0.76 0.7 
  AQ Imagination     -0.12 -1.26, 0.32 0.2 
 Qualification attainment     0.36 2.85, 9.10 <0.0001 
 Affective diagnosis     0.15 -0.76, 7.12 0.1 
         
Functioning        
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PSP 0.37 6.73 <0.0001 0.59    
 AQ Social     0.08 -0.01, 0.02 0.5 
 AQ Attention Switching     -0.22 -0.03, -0.00 0.07 
 AQ Attention to Detail     0.03 -0.01, 0.02 0.7 
 AQ Communication     -0.15 -0.03, 0.01 0.3 
   AQ Imagination     -0.27 -0.04, -0.01 0.01 
 Qualification attainment     0.25 0.02, 0.15 0.01 
 Affective diagnosis     0.12 -0.03, 0.13 0.2 
         
Symptoms        
PANSS Total 0.44 10.32 <0.0001 0.79    
 AQ Social     -0.02 -0.01, 0.01 0.9 
 AQ Attention Switching     0.16 -0.00, 0.02 0.1 
 AQ Attention to Detail     0.14 0.00, 0.02 0.1 
 AQ Communication     0.32 0.00, 0.03 0.02 
  AQ Imagination     0.13 -0.00, 0.02 0.2 
 Qualification attainment     -0.31 -0.13, -0.03 0.001 
PANSS General  0.40 8.69 <0.0001 0.67    
 AQ Social     -0.05 -0.79, 0.53 0.7 
  AQ Attention Switching     0.14 -0.25, 1.20 0.2 
 AQ Attention to Detail     0.09 -0.30, 0.90 0.3 
 AQ Communication     0.39 0.32, 2.01 0.008 
  AQ Imagination        0.10 -0.37, 1.05 0.3  
 Qualification attainment     -0.25 -6.47, -0.90 0.01 
 
 
Table 4: Associations of autism traits with Quality of Life, current functioning, and current symptoms; Multinomial logistic 
regressions overall model significance, Nagelkerke‘s R², and significantly contributing predictors for each quartile compared to 
the reference group (1st quartile) 
  Model results R2 
  Outcome 1: Social QoL; χ²=65.57, p<0.0001  
  Q1 (ref) Q2 Q3 Q4 0.57 
AQ Social  - 0.70 (0.49, 1.00) 0.72 (0.47, 1.09) 0.57 (0.36, 0.90)*  
AQ Attention Switching  - 0.76 (0.47, 1.23) 0.58 (0.34, 0.98) 0.54 (0.31, 0.93)*  
AQ Attention to Detail  - 1.20 (0.85, 1.69) 1.81 (1.20, 2.74)* 1.27 (0.84, 1.91)  
AQ Communication  - 1.21 (0.76, 1.94) 0.75 (0.43, 1.31) 1.23 (0.71, 2.14)  
AQ Imagination  - 0.58 (0.39, 0.88)* 0.54 (0.33, 0.89)* 0.65 (0.40, 1.06)  
Affective diagnosis    0.20 (0.02, 2.26) 0.26 (0.02, 2.90) 0.44 (0.04, 4.37)  
Qualification attainment   2.69 (0.56, 13.04) 3.35 (0.53, 21.22) 11.18 (1.75, 71.46)  
  Outcome 2: Vocational QoL; χ²=40.99, p=0.006  
  Q1 (ref) Q2 Q3 Q4 0.41 
AQ Social  - 1.22 (0.87, 1.71) 1.09, (0.80, 1.48) 1.12 (0.75, 1.66)  
AQ Attention Switching  - 0.62 (0.41, 0.94)* 0.56 (0.38, 0.84)* 0.56 (0.35, 0.89)*  
AQ Attention to Detail  - 1.05 (0.77, 1.42) 1.04 (0.78, 1.38) 1.16 (0.81, 1.65)  
AQ Communication  - 1.00 (0.66, 1.52) 1.33 (0.89, 1.99) 1.24 (0.74, 2.07)  
AQ Imagination  - 0.80 (0.55, 1.18) 0.78 (0.55, 1.10) 0.55 (0.36, 0.86)*  
Affective diagnosis    0.35 (0.05, 2.60) 0.23 (0.03, 1.68) 1.85 (0.32, 10.81)  
Qualification attainment   1.55 (0.39, 6.14) 1.66 (0.45, 6.15) 6.76 (1.20, 38.03)*  
  Outcome 3: Functioning (SOFAS); χ²=53.73, p<0.0001  
  Q1 (ref) Q2 Q3 Q4 0.50 
AQ Social  - 1.08 (0.80, 1.45) 1.21 (0.85, 1.72) 1.20 (0.79, 1.82)  
AQ Attention Switching  - 0.73 (0.50, 1.08) 0.59 (0.38, 0.91)* 0.56 (0.35, 0.91)*  
AQ Attention to Detail  - 0.95 (0.71, 1.28) 1.12 (0.80, 1.56) 1.29 (0.88, 1.88)  
AQ Communication  - 0.96 (0.65, 1.41) 0.87 (0.56, 1.36) 0.75 (0.45, 1.25)  
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AQ Imagination  - 0.90 (0.63, 1.28) 0.50 (0.32, 0.79)** 0.68 (0.42, 1.08)  
Affective diagnosis    2.42 (0.21, 28.16) 4.72 (0.38, 58.66) 7.34 (0.59, 91.90)  
Qualification attainment   2.58 (0.68, 9.76) 2.63 (0.55, 12.61) 12.79 (2.08, 78.48)**  
  Outcome 4: PANSS Positive; χ²=34.64, p=0.01  
  Q1 (ref) Q2 Q3 Q4 0.35 
AQ Social  - 1.10 (0.77, 1.57) 1.29 (0.92, 1.80) 0.86 (0.61, 1.23)  
AQ Attention Switching  - 0.90 (0.64, 1.27) 0.91 (0.64, 1.29) 1.19 (0.79, 1.79)  
AQ Attention to Detail  - 1.18 (0.88, 1.58) 1.18 (0.88, 1.58) 1.41 (1.02, 1.95)*  
AQ Communication  - 0.94 (0.63, 1.42) 1.06 (0.71, 1.59) 1.62 (1.00, 2.61)*  
AQ Imagination  - 1.05 (0.73, 1.50) 0.94 (0.67, 1.32) 1.02 (0.70, 1.48)  
Qualification attainment   0.50 (0.13, 1.92) 0.24 (0.07, 1.00) 0.31 (0.07, 1.34)  
  Outcome 5 PANSS Negative; χ²=46.98, p<0.0001  
  Q1 (ref) Q2 Q3 Q4 0.44 
AQ Social  - 0.83 (0.58, 1.18) 0.88 (0.63, 1.23) 1.07 (0.76, 1.52)  
AQ Attention Switching  - 1.05 (0.76, 1.46) 1.37 (0.92, 2.02) 1.19 (0.78, 1.80)  
AQ Attention to Detail  - 0.97 (0.74, 1.29) 0.97 (0.72, 1.32) 1.08 (0.77, 1.49)  
AQ Communication  - 1.22 (0.81, 1.83) 1.62 (1.04, 2.53)* 1.24 (0.79, 1.97)  
AQ Imagination  - 0.94 (0.65, 1.38) 1.10 (0.75, 1.61) 1.59 (1.05, 2.40)*  
Qualification attainment   0.38 (0.10, 1.45) 0.29 (0.07, 1.18) 0.21 (0.05, 0.94)*  
Note: data are OR‘s with 95% confidence intervals 
*)p<0.05;  
**)p<0.01; 
Categorical variables were constructed as follows: Social QoL (2-17=Q1, 19-29=Q2, 30-41=Q3, 42-48=Q4), Vocational QoL 
(0-2=Q1, 3-9=Q2, 10-24=Q3, 26-30=Q4), SOFAS (21-40=Q1, 41-45=Q2, 46-61=Q3, 63-95=Q4), PANSS Positive (7-8=Q1; 
9-10=Q2; 11-16=Q3; 17-30=Q4), PANSS Negative (7-8=Q1, 9-11=Q2, 12-16=Q3, 17-31=Q4). 
 
 
Table 5. Optimal AQ cut-off, cut-off at 26 and cut-off at 32 
Optimal cut off AQ score Sensitivity % Specificity % J-statistic 
PANSS positive 25.5 59.1 81.5 0.406 
PANSS negative 19.5 87.5 60.3 0.478 
PANSS general 22.5 88.5 73.3 0.618 
PANSS total 19.5 91.3 61.9 0.532 
QLS total 22.5 84.0 69.4 0.534 
QLS social 23.5 76.2 72.7 0.489 
QLS engagement 23.5 72.0 74.2 0.462 
SOFAS 19.5 80.8 59.0 0.398 
PSP 19.5 79.2 57.1 0.363 
     
Cut off at 26 AQ score Sensitivity % Specificity % J-statistic 
PANSS positive 26.5 54.5 84.6 0.392 
PANSS negative 26.5 41.7 81.0 0.226 
PANSS general 26.5 53.8 86.7 0.405 
PANSS total 26.5 52.2 84.1 0.363 
QLS total 26.5 52.0 85.5 0.375 
QLS social 26.5 47.6 81.8 0.294 
         
23 
 
QLS engagement 26.5 48.0 83.9 0.319 
SOFAS 26.5 42.3 82.0 0.243 
PSP 26.5 45.8 82.5 0.284 
     
Cut off at 32 AQ score Sensitivity % Specificity % J-statistic 
PANSS positive 32.5 13.6 96.9 0.106 
PANSS negative 32.5 12.5 96.8 0.093 
PANSS general 32.5 11.5 96.7 0.082 
PANSS total 32.5 13.0 96.8 0.099 
QLS total 32.5 16.0 98.4 0.144 
QLS social 32.5 19.0 98.5 0.175 
QLS engagement 32.5 16.0 98.4 0.144 
SOFAS 32.5 11.5 96.7 0.083 
PSP 32.5 16.7 98.4 0.151 
 
         
